Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi Tries To Quash Bristol Rumors; M&A Efforts Center On Biotech, Japan

Executive Summary

Sanofi-Aventis' merger and acquisition efforts will focus on biotech firms and Japanese companies, CEO Gerard Le Fur maintained Feb. 13

You may also be interested in...



Schering Jumps On Organon Buy; Will Late-Stage M&A Keep Fueling Pharma?

Pharmaceutical companies unveiling mergers and acquisitions in the first quarter were among those rewarded by Wall Street

Schering Jumps On Organon Buy; Will Late-Stage M&A Keep Fueling Pharma?

Pharmaceutical companies unveiling mergers and acquisitions in the first quarter were among those rewarded by Wall Street

AstraZeneca Cuts 3,000 Manufacturing Jobs, Pares Down Therapeutic Areas

AstraZeneca's focus on improving manufacturing efficiencies, on the heels of similar moves by Merck and Pfizer, may signal that manufacturing is the next target for industry cost-cutting initiatives

Related Content

UsernamePublicRestriction

Register

PS048060

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel